Dr Erika Nemeth appointed as Operations Manager of Synexus Hungary
Michael Fort, CEO of Synexus, commented: "We are delighted that Erika is joining us. Her experience of the Hungarian market will be invaluable as will her drive and determination to help deliver the growth we are targeting in this important area."
The Hungarian clinical hub site, which is part of a network of Synexus sites across Eastern Europe, is involved in several major studies for big pharma as well as a raft of smaller studies. Hungary is proving to be one of the most attractive countries for Synexus in the running of clinical trials as the hub site has access to hundreds of thousands of patients. Erika's appointment will help to further strengthen Synexus' position in this vital growth area.
Have more questions? Contact us for more information


